DJ Aptose Biosciences Says CFO Gregory Chow to Resign
By Stephen Nakrosis
Aptose Biosciences Inc. on Tuesday said Gregory Chow, the company's chief financial officer, is resigning "to pursue an opportunity at a private biopharma company."
Aptose said William Rice, the company's chairman, president and chief executive will serve as chief accounting officer until a permanent replacement is announced. The company's Chief Business Officer, Jotin Marango, will assume the duties of CFO until the replacement is announced, Aptose said.
Aptose also said it plans to enter into a consulting agreement with Mr. Chow that would be effective upon his March 26 departure.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 23, 2021 16:49 ET (20:49 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.